German Spondyloarthritis Inception Cohort

  • STATUS
    Recruiting
  • End date
    Jul 22, 2030
  • participants needed
    1000
  • sponsor
    Charite University, Berlin, Germany
Updated on 22 October 2021
psoriasis
back pain
arthritis
crohn's disease
spondyloarthropathy
axial spondyloarthritis
uveitis

Summary

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.

Details
Condition Ankylosing Spondylitis, Ulcerative Colitis, Ankylosing spondylitis, Non-radiographic Axial Spondyloarthritis, Non-radiographic Axial Spondyloarthritis (Nr-axSpA), Axial Psoriatic Arthritis (axPsA), Inflammatory Bowel Disease, Inflammatory bowel disease, Ulcerative Colitis (Pediatric), acute anterior uveitis, Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA), Crohn's Disease (Pediatric), Crohn's Disease, crohns disease
Clinical Study IdentifierNCT01277419
SponsorCharite University, Berlin, Germany
Last Modified on22 October 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients with definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis
Patients with definite diagnosis of Crohn's disease
Patients with definite diagnosis of acute anterior uveitis
Patients with definite diagnosis of psoriatic arthritis with axial involvement
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note